Buy & Sell 22nd Century Group Inc (XXII) – 22nd Century Group Inc Price Today
Aura AI Summary
Key Stats
- $3.10MMarket Cap
- TechnologySector
- -91.06%3M Drawdown
- -$5.13MEnterprise Value
- -Dividend Yield
- 58% Buy | 42% SellTrading Activity
- 4 daysTypical Hold Time
22nd Century Group Inc (XXII) is currently valued at a market capitalization of $3.10M, with an enterprise value of -$5.13M. Over the past 52 weeks, 22nd Century Group Inc has traded between a low of $0.56 and a high of $396.75, highlighting its annual price range. Over the past three months, 22nd Century Group Inc has recorded a drawdown of -91.06%, reflecting recent price volatility. On average, investors hold 22nd Century Group Inc for approximately 4 days, indicating typical investor behavior on the platform.
About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Most Recent News
Class action deadlines near for investors in ATRA, COTY, SMCI, and IBRX over alleged securities fraud.
Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in securities fraud class actions against Atara Biotherapeutics, Coty Inc., Super Micro Computer, and ImmunityBio. The lawsuits allege these comp...
Buscar Company advances key permits for Treasure Canyon gold mine in California.
Buscar Company announced significant progress in obtaining permits for its Treasure Canyon Mine project in Plumas County, California. Several permits, including a burn permit and dust control plan, have been approved, while other applications are und...
Investigations launched into fairness of merger deals for Veris, XOMA, Organon, and RE/MAX shares.
Brodsky & Smith LLC has announced investigations into whether the boards of Veris Residential, XOMA Royalty Corporation, Organon & Co., and RE/MAX Holdings breached their fiduciary duties in recent merger agreements. The investigations focus on wheth...